Mohammed Azman – CEO, PERKESO, Malaysia
Dato’ Sri Dr Mohammed Azman, CEO at PERKESO, the Malaysian Social Security Organization, explains PERKESO’s main areas of focus as well as the current health burdens the organization is looking…
Address: Unit 1104, Level 11 Uptown 2, No. 2, Jalan SS21/37 Damansara Uptown 47400 Petaling Jaya, Selangor,Malaysia
Tel: +60 3 7724 6200
Web: http://www.parexel.com/about/global-presence/asia-pacific/malaysia/
Over the past 27 years, PAREXEL has developed significant expertise to assist clients in the worldwide pharmaceutical, biotechnology and medical device industries with the development and launch of their products in order to bring safe and effective treatments to the global marketplace for the patients who need them. Headquartered near Boston, Massachusetts, PAREXEL operates in 70 locations throughout 54 countries around the world, and has over 9,500 employees.
We are a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services.
PAREXEL has been providing strategic pharmaceutical research and development services for the biopharmaceutical and medical device industries for more than 25 years. Our unsurpassed global network of in-depth expertise, clinical resources, and technology makes us the partner of choice for your complete development needs across every phase of the product lifecycle… every therapeutic area… and every geographic region. Our broad range of services includes:
Early stage development and proof-of-concept studies
Complete Phase III clinical research capabilities, with innovative site and patient recruitment approaches
Risk management and pharmacovigilance programs
Global pharmaceutical regulations compliance, pricing, and marketing strategies
Biosimilar product development
Industry-leading eClinical and medical imaging technologies
Dato’ Sri Dr Mohammed Azman, CEO at PERKESO, the Malaysian Social Security Organization, explains PERKESO’s main areas of focus as well as the current health burdens the organization is looking…
Jennifer Lopez, executive director of the British Malaysian Chamber of Commerce, discusses foreign investment trends in Malaysia and how the chamber is serving its members, especially UK companies operating in…
Lim Teng Chyuan, president of the Malaysian Association for Pharmaceutical Suppliers (MAPS), discusses the association’s role in solving and supporting its members with the numerous regulatory issues and compliance requirements…
Amrahi Buang, president of the Malaysian Pharmaceutical Society details the ‘lack’ of recognition and integration of pharmacists in Malaysia. He also explains the complex dual healthcare system and the governmental…
The managing director of Boston Consulting Group Malaysia discusses the gap between public and private healthcare in the country, and what can be done to bridge it. What appears…
Professor Kenneth K. C. Lee, Head of the School of Pharmacy at Monash University Malaysia, discusses the institution’s position as a hub for health economics in the Asia Pacific region…
Rhenu Bhuller provides insight into Malaysia’s healthcare industry positioning in the Southeast Asian region and the ability to provide affordable quality healthcare in a country that is naturally diverse as…
Klaus Boehncke and Yennie Tan from PwC Malaysia discuss the factors that will make the country a hub for medical tourism and the importance of listening to patient demands at…
Dr. Hassan, founder and CEO of Healwell and House of Healin, brings research and entrepreneurship together with the aim of turning Malaysian traditions into scientific innovation. Could you share…
Alan Ong, executive vice president for the Asia/Pacific region at INC Research, outlines the key challenges and opportunities that CROs face in the Malaysian clinical trial segment and describes INC’s…
Bayer Malaysia’s managing director, Thomas Steffen, discusses the key differences and opportunities offered by the Malaysian market and calls for more information to help the promotion of oral contraception in…
Sanofi’s general manager for Malaysia, Singpoare and Brunei discusses the benefits of implementing of a new channel business model and proudly showcases the dengue vaccine, 20 years after the company initiated…
See our Cookie Privacy Policy Here